Quest Diagnostics (DGX) Share-based Compensation (2009 - 2026)

Quest Diagnostics has disclosed Share-based Compensation across 18 years of filings, most recently posting $6.0 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 500.0% year-over-year to $6.0 million; the TTM figure through Jun 2026 stood at $88.0 million (down 1.12% YoY), while the FY2025 annual figure was $88.0 million, changed 0.0% from the prior year.
• Share-based Compensation came in at $6.0 million for Q2 2026 at Quest Diagnostics, down from $37.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $42.0 million in Q1 2025 to a low of $1.0 million in Q2 2025.
• Average Share-based Compensation over 5 years is $20.7 million, with a median of $19.5 million recorded in 2023.
• Year-over-year, Share-based Compensation slumped 94.74% in 2025 and jumped 500.0% in 2026.
• Over 5 years, Share-based Compensation stood at $22.0 million in 2022, then fell by 13.64% to $19.0 million in 2023, then surged by 42.11% to $27.0 million in 2024, then slipped by 7.41% to $25.0 million in 2025, then tumbled by 76.0% to $6.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $6.0 million in Q2 2026, $37.0 million in Q1 2026, and $25.0 million in Q4 2025.